These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 9777972)

  • 1. Preclinical promise of becaplermin (rhPDGF-BB) in wound healing.
    LeGrand EK
    Am J Surg; 1998 Aug; 176(2A Suppl):48S-54S. PubMed ID: 9777972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chronic wound fluid on the structure and biological activity of becaplermin (rhPDGF-BB) and becaplermin gel.
    Castronuovo JJ; Ghobrial I; Giusti AM; Rudolph S; Smiell JM
    Am J Surg; 1998 Aug; 176(2A Suppl):61S-67S. PubMed ID: 9777974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Becaplermin gel (Regranex gel)].
    Senet P
    Ann Dermatol Venereol; 2004 Apr; 131(4):351-8. PubMed ID: 15258509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of becaplermin (rhPDGF-BB) gel for chronic nonhealing ulcers. A retrospective analysis.
    Mandracchia VJ; Sanders SM; Frerichs JA
    Clin Podiatr Med Surg; 2001 Jan; 18(1):189-209, viii. PubMed ID: 11344978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Becaplermin: recombinant platelet derived growth factor, a new treatment for healing diabetic foot ulcers.
    Nagai MK; Embil JM
    Expert Opin Biol Ther; 2002 Feb; 2(2):211-8. PubMed ID: 11849120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study.
    Wieman TJ; Smiell JM; Su Y
    Diabetes Care; 1998 May; 21(5):822-7. PubMed ID: 9589248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of recombinant growth factors in wound healing.
    Robson MC; Mustoe TA; Hunt TK
    Am J Surg; 1998 Aug; 176(2A Suppl):80S-82S. PubMed ID: 9777977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of platelet-derived growth factor-BB on bone formation in calvarial defects: an experimental study in rabbits.
    Vikjaer D; Blom S; Hjørting-Hansen E; Pinholt EM
    Eur J Oral Sci; 1997 Feb; 105(1):59-66. PubMed ID: 9085030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of topical recombinant human platelet-derived growth factor-BB (becaplermin) in healing of chronic mixed arteriovenous lower extremity diabetic ulcers.
    Miller MS
    J Foot Ankle Surg; 1999; 38(3):227-31. PubMed ID: 10384364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental study on recombinant human platelet-derived growth factor gel in a diabetic rat model of cutaneous incisal wound healing].
    Sun TZ; Fu XB; Zhao ZL; Chen W; Sun XQ; Zhou G; Shen ZY
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Oct; 15(10):596-9. PubMed ID: 14552680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of platelet-derived growth factor BB in accelerating wound healing in aged versus young animals: the impact of tissue hypoxia.
    Wu L; Brucker M; Gruskin E; Roth SI; Mustoe TA
    Plast Reconstr Surg; 1997 Mar; 99(3):815-22; discussion 823-4. PubMed ID: 9047202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy of becaplermin (rhPDGF-BB) gel. Becaplermin Gel Studies Group.
    Wieman TJ
    Am J Surg; 1998 Aug; 176(2A Suppl):74S-79S. PubMed ID: 9777976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors in the fracture microenvironment induce primary osteoblast angiogenic cytokine production.
    Bouletreau PJ; Warren SM; Spector JA; Steinbrech DS; Mehrara BJ; Longaker MT
    Plast Reconstr Surg; 2002 Jul; 110(1):139-48. PubMed ID: 12087245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of nonclinical toxicology studies of becaplermin (rhPDGF-BB).
    Knight EV; Oldham JW; Mohler MA; Liu S; Dooley J
    Am J Surg; 1998 Aug; 176(2A Suppl):55S-60S. PubMed ID: 9777973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periodontal regeneration in humans using recombinant human platelet-derived growth factor-BB (rhPDGF-BB) and allogenic bone.
    Nevins M; Camelo M; Nevins ML; Schenk RK; Lynch SE
    J Periodontol; 2003 Sep; 74(9):1282-92. PubMed ID: 14584860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hyperbaric oxygen and growth factors on rabbit ear ischemic ulcers.
    Zhao LL; Davidson JD; Wee SC; Roth SI; Mustoe TA
    Arch Surg; 1994 Oct; 129(10):1043-9. PubMed ID: 7944933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of rhPDGF-BB on bone turnover during periodontal repair.
    Sarment DP; Cooke JW; Miller SE; Jin Q; McGuire MK; Kao RT; McClain PK; McAllister BS; Lynch SE; Giannobile WV
    J Clin Periodontol; 2006 Feb; 33(2):135-40. PubMed ID: 16441739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human platelet-derived growth factor-BB (becaplermin) for healing chronic lower extremity diabetic ulcers: an open-label clinical evaluation of efficacy.
    Embil JM; Papp K; Sibbald G; Tousignant J; Smiell JM; Wong B; Lau CY
    Wound Repair Regen; 2000; 8(3):162-8. PubMed ID: 10886806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human platelet-derived growth factor-BB augmentation of new-bone formation in a rat model of distraction osteogenesis.
    Moore DC; Ehrlich MG; McAllister SC; Machan JT; Hart CE; Voigt C; Lesieur-Brooks AM; Weber EW
    J Bone Joint Surg Am; 2009 Aug; 91(8):1973-84. PubMed ID: 19651957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histologic and Histomorphometric Comparison of Bone Regeneration Between Bone Morphogenetic Protein-2 and Platelet-Derived Growth Factor-BB in Experimental Groups.
    Guven G; Gultekin BA; Guven GS; Guzel E; Furat S; Ersanli S
    J Craniofac Surg; 2016 May; 27(3):805-9. PubMed ID: 27092911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.